LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
US Stock MarketDetailed Quotes
IMNM Immunome
- 10.540
- -0.560-5.05%
Close Dec 27 16:00 ET
- 10.540
- 0.0000.00%
Post 20:01 ET
657.87MMarket Cap-1.33P/E (TTM)
11.160High10.365Low2.46MVolume11.000Open11.100Pre Close25.71MTurnover5.43%Turnover RatioLossP/E (Static)62.42MShares30.95852wk High3.06P/B476.86MFloat Cap8.97052wk Low--Dividend TTM45.24MShs Float63.780Historical High--Div YieldTTM7.16%Amplitude2.090Historical Low10.464Avg Price1Lot Size
Immunome Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -18.37%2.91M | -44.55%2.36M | -56.47%1.03M | 14.02M | 3.83M | 3.57M | 4.26M | 2.36M | 0 | 0 |
| Operating revenue | -18.37%2.91M | -44.55%2.36M | -56.47%1.03M | --14.02M | --3.83M | --3.57M | --4.26M | --2.36M | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 469.97%46.73M | 259.32%36.06M | 212.71%21.37M | 15.84%42.75M | 127.01%17.68M | -3.94%8.2M | 12.44%10.04M | -41.35%6.84M | 46.41%36.9M | -0.73%7.79M |
| Selling and administrative expenses | 117.74%9.53M | 61.53%6.98M | 105.51%6.01M | 44.23%19.66M | 127.44%8.04M | 32.22%4.38M | 34.62%4.32M | -18.29%2.92M | 22.85%13.63M | 2.20%3.54M |
| -General and administrative expense | 117.74%9.53M | 61.53%6.98M | 105.51%6.01M | 44.23%19.66M | 127.44%8.04M | 32.22%4.38M | 34.62%4.32M | -18.29%2.92M | 22.85%13.63M | 2.20%3.54M |
| Research and development costs | 873.06%37.2M | 408.80%29.08M | 292.77%15.37M | -0.79%23.09M | 126.65%9.64M | -26.83%3.82M | -0.02%5.72M | -51.56%3.91M | 64.93%23.27M | -3.03%4.25M |
| Operating profit | -845.74%-43.82M | -483.70%-33.7M | -355.04%-20.35M | 22.15%-28.73M | -77.87%-13.85M | 45.71%-4.63M | 35.32%-5.77M | 61.64%-4.47M | -46.41%-36.9M | 0.73%-7.79M |
| Net non-operating interest income expense | 1,088.19%3.42M | 1,699.54%3.89M | 1,296.52%2.81M | 54,380.00%2.72M | 201,800.00%2.02M | 28,700.00%288K | 10,700.00%216K | 20,000.00%201K | 150.00%5K | 120.00%1K |
| Non-operating interest income | 1,088.19%3.42M | 1,699.54%3.89M | 1,296.52%2.81M | 54,380.00%2.72M | 201,800.00%2.02M | 28,700.00%288K | 10,700.00%216K | 20,000.00%201K | --5K | --1K |
| Other net income (expense) | -6.71M | -6.31M | -111.95M | -80.8M | ||||||
| Special income (charges) | ---6.71M | ---6.31M | ---111.95M | ---80.8M | ---80.8M | --0 | --0 | --0 | --0 | ---- |
| -Less:Other special charges | --6.71M | --6.31M | --111.95M | --80.8M | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | -984.00%-47.1M | -550.03%-36.12M | -2,932.60%-129.49M | -189.48%-106.81M | -1,089.75%-92.63M | 49.08%-4.35M | 37.73%-5.56M | 63.36%-4.27M | -49.31%-36.9M | 0.84%-7.79M |
| Income tax | ||||||||||
| Net income | -984.00%-47.1M | -550.03%-36.12M | -2,932.60%-129.49M | -189.48%-106.81M | -1,089.75%-92.63M | 49.08%-4.35M | 37.73%-5.56M | 63.36%-4.27M | -49.31%-36.9M | 0.84%-7.79M |
| Net income continuous Operations | -984.00%-47.1M | -550.03%-36.12M | -2,932.60%-129.49M | -189.48%-106.81M | -1,089.75%-92.63M | 49.08%-4.35M | 37.73%-5.56M | 63.36%-4.27M | -49.31%-36.9M | 0.84%-7.79M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -984.00%-47.1M | -550.03%-36.12M | -2,932.60%-129.49M | -189.48%-106.81M | -1,089.75%-92.63M | 49.08%-4.35M | 37.73%-5.56M | 63.36%-4.27M | -49.31%-36.9M | 0.84%-7.79M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 0 | 622K | 0 | |||||||
| Net income attributable to common stockholders | -984.00%-47.1M | -550.03%-36.12M | -2,932.60%-129.49M | -184.68%-106.81M | -1,089.75%-92.63M | 52.54%-4.35M | 37.73%-5.56M | 63.36%-4.27M | -51.83%-37.52M | 0.84%-7.79M |
| Basic earnings per share | -116.67%-0.78 | -30.43%-0.6 | -3,485.71%-12.55 | -74.11%-5.38 | -234.65%-2.1417 | 52.00%-0.36 | 37.84%-0.46 | 63.54%-0.35 | -44.39%-3.09 | 1.54%-0.64 |
| Diluted earnings per share | -116.67%-0.78 | -30.43%-0.6 | -3,485.71%-12.55 | -74.11%-5.38 | -234.65%-2.1417 | 52.00%-0.36 | 37.84%-0.46 | 63.54%-0.35 | -44.39%-3.09 | 1.54%-0.64 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |